Is Kaneka (TSE:4118) Still Cheap As Strong Q1 And Higher Guidance Lift Confidence?

Kaneka (TSE:4118) is back in focus after reporting first quarter earnings on 13 August 2026, alongside updated full year guidance and higher dividend projections that signal management’s confidence in the current business trajectory.

See our latest analysis for Kaneka.

The earnings release and higher dividend guidance have arrived after a strong run in Kaneka’s share price, with a year to date share price return of 39.36% and a 1 year total shareholder return of 46.67% that points to building momentum.

If Kaneka’s recent move has you thinking about where else growth stories may emerge, this could be a good moment to scan the market using our screener of 13 top founder-led companies

Bulls point to Kaneka’s stronger first quarter figures and higher dividend guidance. Bears question how much of that is already in the 39% year to date move. The valuation section tests which side current pricing favours.

Preferred P/E of 10.4x: Is it justified?

Kaneka is trading on a P/E of 10.4x, and the company’s own data signals that this points to good value relative to both its estimated fair level and its peers.

The P/E ratio compares the current share price to earnings per share. It reflects what investors are paying for each unit of Kaneka’s earnings today. For a materials and chemicals group with multiple segments and steady revenue of ¥835,981, this is a simple way to benchmark how the market is pricing its profit stream.

According to the checks provided, Kaneka is viewed as good value on several fronts. It trades at a 6.1% discount to an internal fair value estimate based on future cash flows, with the SWS DCF model putting fair value at ¥6,589.57 against a last close of ¥6,185. A similar message appears when looking at relative value. The current P/E of 10.4x is below an estimated fair P/E of 12.5x, which is presented as a level the ratio could reasonably move towards if the market re-rated the stock. It is also below the JP Chemicals industry average of 12.5x and the peer group average of 15.6x. This implies the market is pricing Kaneka’s earnings at a lower multiple than comparable companies despite 5 year earnings growth of 2.6% a year and a 58.2% earnings uplift over the past year.

The gap between 10.4x and the higher fair and peer multiples is material. It suggests the current price may not fully reflect the company’s recent profit growth, improved net margin from 2.8% to 4.3%, and the fact that its 1 year total return of 46.67% has outpaced both the broader JP market and the JP Chemicals industry.

Explore the SWS fair ratio for Kaneka

Result: Price-to-earnings of 10.4x (UNDERVALUED)

However, there are still risks if Kaneka’s recent earnings uplift and net margin of 4.3% prove hard to sustain, or if revenue growth of 2.37% slows.

Find out about the key risks to this Kaneka narrative.

Another view on Kaneka’s value

The P/E story for Kaneka points to value, but the SWS DCF model tells a slightly different story. It puts fair value at ¥6,589.57 per share, compared with the current price of ¥6,185. That implies the stock trades at a 6.1% discount. How much weight should you give to that cash flow view?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kaneka for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 26 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

Next Steps

There is clearly a mix of optimism and caution around Kaneka in this earnings season, so it makes sense to review the figures yourself and decide how compelling the risk reward trade off looks. To help you weigh both sides quickly, start with the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Kaneka?

If Kaneka has sharpened your interest in new opportunities, now is the time to widen your search and line up the next set of candidates.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com